Dashboard
Portfolios
Watchlist
Community
Discover
Screener
Narratives
Your Valuation
🌎 Global
Global
United States
Australia
United Kingdom
Canada
India
China
Argentina
Austria
Bahrain
Bangladesh
Belgium
Bermuda
Botswana
Brazil
Bulgaria
Chile
Colombia
Croatia
Cyprus
Czech Republic
Denmark
Egypt
Estonia
Finland
France
Germany
Ghana
Greece
Hong Kong
Hungary
Iceland
Indonesia
Ireland
Israel
Italy
Ivory Coast
Jamaica
Japan
Jordan
Kenya
Kuwait
Latvia
Lithuania
Luxembourg
Malawi
Malaysia
Malta
Mauritius
Mexico
Morocco
Namibia
Netherlands
New Zealand
Nigeria
Norway
Oman
Pakistan
Palestinian Authority
Peru
Philippines
Poland
Portugal
Qatar
Romania
Russia
Saudi Arabia
Serbia
Singapore
Slovakia
Slovenia
South Africa
South Korea
Spain
Sri Lanka
Sweden
Switzerland
Taiwan
Tanzania
Thailand
Trinidad & Tobago
Tunisia
Turkey
Uganda
Ukraine
United Arab Emirates
Venezuela
Vietnam
Zambia
Zimbabwe
Create a narrative
Global Community
Our community narratives are driven by numbers and valuation.
Create a narrative
Community Investing Ideas
Global Weekly Picks
Novo Nordisk
BA
bactrian
Community Contributor
A Quality Compounder Marked Down on Overblown Fears
Novo Nordisk , a global leader in diabetes and obesity treatments, is trading at a deep discount to both its historical multiples and intrinsic value. The ADR is now priced at $47.05 , reflecting a normalized P/E ratio of just 13.4× , down from a five-year average closer to 25–30×.
View narrative
US$120.72
FV
57.7% undervalued
intrinsic discount
15.71%
Revenue growth p.a.
Set Fair Value
26
users have liked this narrative
7
users have commented on this narrative
73
users have followed this narrative
New
narrative
ASML Holding
IN
Investingwilly
Community Contributor
Why Now is the Time to buy ASML
What Does ASML Do? ASML Holding N.V. is a Dutch company and the world’s only supplier of extreme ultraviolet (EUV) lithography machines —a critical technology used to produce the world’s most advanced computer chips.
View narrative
US$1.00k
FV
28.0% undervalued
intrinsic discount
15.17%
Revenue growth p.a.
Set Fair Value
35
users have liked this narrative
6
users have commented on this narrative
96
users have followed this narrative
Updated
narrative
Wyndham Hotels & Resorts
ZW
Zwfis
Community Contributor
Wyndham Continues Global Expansion with 19% Ancillary Revenue Growth
WH is a company that I actually took interest in a couple of months ago when I happened to stay at one of their franchise hotels. I had to leave early in the morning at like 4 and when I went out to the parking lot I was astounded that in the little town I was was absolutely full.
View narrative
US$105.80
FV
20.6% undervalued
intrinsic discount
13.23%
Revenue growth p.a.
Set Fair Value
7
users have liked this narrative
2
users have commented on this narrative
15
users have followed this narrative
New
narrative
All companies
Popular
Undervalued
Overvalued
Load previous narratives
Greencore Group
AN
AnalystLowTarget
Consensus Narrative from 4 Analysts
Shifting Dietary Preferences And Rising Costs Will Undermine Prospects
Key Takeaways Shifting consumer preferences and mounting regulatory scrutiny threaten Greencore's processed food model and could erode future profitability and revenue stability. Heavy reliance on UK retailers and risks from climate impacts, cost inflation, and a challenging acquisition increase earnings volatility and operational uncertainty.
View narrative
UK£1.85
FV
36.2% overvalued
intrinsic discount
3.47%
Revenue growth p.a.
Set Fair Value
0
users have liked this narrative
0
users have commented on this narrative
0
users have followed this narrative
1 day ago
author updated this narrative
Renishaw
AN
AnalystLowTarget
Consensus Narrative from 9 Analysts
Obsolete Metrology And Global Trade Risks Will Erode Value
Key Takeaways Intensifying competition, rapid technological evolution, and price pressures threaten margins and market share, forcing higher R&D investment just to maintain position. Geopolitical and regulatory risks, including trade tensions and sustainability requirements, are increasing costs, supply chain volatility, and unpredictability in earnings.
View narrative
UK£23.80
FV
25.4% overvalued
intrinsic discount
5.00%
Revenue growth p.a.
Set Fair Value
0
users have liked this narrative
0
users have commented on this narrative
0
users have followed this narrative
1 day ago
author updated this narrative
Serco Group
AN
AnalystLowTarget
Consensus Narrative from 10 Analysts
Government Insourcing Trends Will Curb Contract Wins Despite Strong Orders
Key Takeaways Heightened government scrutiny, insourcing trends, and rapid technology adoption threaten contract visibility, margins, and long-term revenue stability. Heavy sector and geographic concentration, plus reputational issues, increase vulnerability to policy shifts and limit profitable market expansion.
View narrative
UK£1.42
FV
53.8% overvalued
intrinsic discount
2.88%
Revenue growth p.a.
Set Fair Value
0
users have liked this narrative
0
users have commented on this narrative
0
users have followed this narrative
1 day ago
author updated this narrative
Rieter Holding
AN
AnalystLowTarget
Consensus Narrative from 3 Analysts
Cyclical Textile Pressures Will Challenge Operations Yet Allow Modest Stabilization
Key Takeaways After Sales growth and strategic automation investments strengthen recurring revenue streams, but ongoing market cyclicality and geopolitical risks cause earnings volatility and limit near-term growth. Elevated debt from recent acquisitions, sluggish order intake, and sector challenges constrain capacity utilization, margin improvements, and future investment flexibility.
View narrative
CHF 79.00
FV
26.3% undervalued
intrinsic discount
15.87%
Revenue growth p.a.
Set Fair Value
0
users have liked this narrative
0
users have commented on this narrative
0
users have followed this narrative
1 day ago
author updated this narrative
Valeo
AN
AnalystLowTarget
Consensus Narrative from 14 Analysts
High-Voltage Setbacks And Trade Tensions Will Crimp Future Outlook
Key Takeaways Weakness in the electrification segment and order cancellations have heightened risk to future top-line performance and growth prospects. Rising geopolitical risks and high investment needs, combined with industry volatility, threaten both margins and market share retention.
View narrative
€8.15
FV
22.5% overvalued
intrinsic discount
1.27%
Revenue growth p.a.
Set Fair Value
0
users have liked this narrative
0
users have commented on this narrative
0
users have followed this narrative
1 day ago
author updated this narrative
Greenpanel Industries
AN
AnalystLowTarget
Consensus Narrative from 16 Analysts
Low-carbon Shifts And Escalating Costs Will Crush Value
Key Takeaways Heavy reliance on MDF leaves the company exposed to substitution risks, margin compression, and volatile earnings due to limited product diversification and pricing pressures. Environmental regulations, rising raw material costs, and new material technologies threaten competitiveness and long-term earnings sustainability.
View narrative
₹230.00
FV
17.3% overvalued
intrinsic discount
20.16%
Revenue growth p.a.
Set Fair Value
0
users have liked this narrative
0
users have commented on this narrative
0
users have followed this narrative
1 day ago
author updated this narrative
Empreendimentos Pague Menos
AN
AnalystLowTarget
Consensus Narrative from 7 Analysts
Brazil Retail Will Falter Amid Digital Competition
Key Takeaways Growing digital health adoption and demographic shifts threaten store volumes, limiting revenue growth and the effectiveness of physical expansion strategies. Intensified competition and rising regulatory burdens risk squeezing margins, increasing operational costs, and dampening overall profitability.
View narrative
R$3.40
FV
12.4% overvalued
intrinsic discount
7.87%
Revenue growth p.a.
Set Fair Value
0
users have liked this narrative
0
users have commented on this narrative
0
users have followed this narrative
1 day ago
author updated this narrative
Sobha
AN
AnalystLowTarget
Consensus Narrative from 16 Analysts
Stagnant Indian Urbanization And Rising Costs Will Weaken Outlook
Key Takeaways Heavy reliance on saturated metro markets and potential oversupply could restrain demand growth and weaken pricing power for future projects. Elevated debt levels, rising regulatory and financing costs, and stricter compliance burdens threaten profitability and margin stability over time.
View narrative
₹1.20k
FV
26.0% overvalued
intrinsic discount
14.54%
Revenue growth p.a.
Set Fair Value
0
users have liked this narrative
0
users have commented on this narrative
0
users have followed this narrative
1 day ago
author updated this narrative
Tatva Chintan Pharma Chem
AN
AnalystLowTarget
Consensus Narrative from 3 Analysts
Rising ESG Pressures And Localization Will Erode Export Outlook
Key Takeaways Escalating regulatory, cost, and localization pressures threaten profitability and market access for Tatva Chintan's export-centric business model. Heavy dependence on core chemical products and rising global competition expose the company to earnings volatility and weakened industry positioning.
View narrative
₹535.00
FV
94.8% overvalued
intrinsic discount
20.48%
Revenue growth p.a.
Set Fair Value
0
users have liked this narrative
0
users have commented on this narrative
0
users have followed this narrative
1 day ago
author updated this narrative
Value any company in seconds
Popular companies